TITLE

Metastatic Breast Carcinoma Mimicking Macronodular Cirrhosis

AUTHOR(S)
Wallace, Gene; Conologue, Theresa L.; Murphy, Timothy J.
PUB. DATE
November 2003
SOURCE
Mayo Clinic Proceedings;Nov2003, Vol. 78 Issue 11, p1431
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Discusses the case of 42-year-old female breast cancer patient. Metastasis of cancer to the liver; Medical history; Rarity of metastatic carcinomatous cirrhosis; Mimicry of macronodular cirrhosis; Prognosis.
ACCESSION #
11286850

 

Related Articles

  • Biology of breast cancers with liver metastases may evolve, affecting treatment options.  // Hem/Onc Today;7/10/2010, Vol. 10 Issue 13, p24 

    The article discusses a retrospective study which examines the evolution of breast cancer with liver metastases in women.

  • Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report.  // Journal of Medical Case Reports;2011, Vol. 5 Issue 1, p495 

    The article presents the case of a 65-year-old Japanese woman flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer. The exact mechanism of flare hypercalcemia remains uncertain, and it is believed that estrogenic properties of tamoxifen may precipitate...

  • Bevacizumab/carboplatin/paclitaxel.  // Reactions Weekly;1/16/2016, Vol. 1584 Issue 1, p44 

    An abstract is presented for article "Liver metastasis of a triple-negative breast cancer and complete remission for 5 years after treatment with combined Bevacizumab/Paclitaxel/ Carboplatin: Case report and review of the literature" by H.Ogata and others, in October 2015 issue of journal Medicine.

  • Editorial. Vivodová, Eva; Foltánová, Tatiana // Acta Facultatis Pharmaceuticae Universitatis Comenianae;Dec2015 Supplement, Vol. 62, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including best practices for rare diseases, national health policy and genetic analysis of hereditary breast ovarian cancer.

  • Citations and Clinicians' Notes: Biology: Prognostic factors.  // Current Medical Literature: Breast Cancer;2003, Vol. 15 Issue 4, p107 

    Presents information on several studies regarding the prognostic factors of breast cancer. "Effect of Family History, Obesity and Exercise on Breast Cancer Risk Among Postmenopausal Women," by C. Carpenter, R. Ross, A. Pagani-Hill and L. Bernstein; "Soy, Isoflavones and Breast Cancer Risk in...

  • Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Tabari�s, S; Dong, Z; Annis, M G; Omeroglu, A; Pepin, F; Ouellet, V; Russo, C; Hassanain, M; Metrakos, P; Diaz, Z; Basik, M; Bertos, N; Park, M; Guettier, C; Adam, R; Hallett, M; Siegel, P M // Oncogene;3/17/2011, Vol. 30 Issue 11, p1318 

    The liver represents the third most frequent site of metastasis in patients with breast cancer. We performed in vivo selection using 4T1 breast cancer cells to identify genes associated with the liver metastatic phenotype. Coincident with the loss of numerous tight-junctional proteins, we...

  • Breast liver metastases--incidence, diagnosis and outcome. Hoe, A. L.; Royle, G. T.; Taylor, I. // Journal of the Royal Society of Medicine;Dec1991, Vol. 84 Issue 12, p714 

    Breast liver metastases are uncommon and have not been well reported. We studied the clinical outcome of 47 patients who developed liver metastases out of 912 breast cancer patients treated between 1982 and 1987, an incidence of 5.2%. The median disease free interval prior to clinical liver...

  • T cell actication with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer. Martinet, O.; Divino, C.M.; Zang, Y.; Gan, Y.; Mandeli, J.; Thung, S.; Pan, P.-Y.; Chen, S.-H. // Gene Therapy;6/15/2002, Vol. 9 Issue 12, p786 

    We have shown that interleukin-12 (IL-12) generated a strong, albeit transient, anti-tumor response, mostly mediated by natural killer (NK) cell. T cell participation, in addition to NK cells, was essential for persistence of the antitumor response. Ligation of 4-1BB, a co-stimulatory receptor...

  • Docetaxel.  // Reactions Weekly;8/16/2008, Issue 1215, p16 

    The article describes the case of a 41-year-old woman who experienced onycholysis while receiving docetaxel for invasive-ductal breast cancer with pulmonary and hepatic metastases. The woman developed swelling, pain and pus discharged from her toe and fingernails after 3 months of palliative...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics